查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1304593

全球必需脂肪酸市场 - 2023-2030

Global Essential Fatty Acids Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 102 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

全球必需脂肪酸市场规模在2022年达到46亿美元，预计到2030年将达到85亿美元，实现利润丰厚的增长。在2023-2030年的预测期内，该市场的复合年增长率为8.1%。

全球对健康和保健的关注与日俱增，这使得消费者越来越意识到营养对整体健康的重要性。消费者正在积极寻找能够提供健康益处的膳食干预措施和补充剂，其中包括推动市场增长的必需脂肪酸（EFA）。

这种日益增长的趋势推动了全球对EFA产品的需求。此外，除膳食补充剂外，EFA还被应用于其他领域，尤其是功能性食品和饮料领域。制造商正在将EFAs添加到各种产品中，如强化饮料、能量棒、谷物和烘焙食品。通过在功能性食品中添加EFAs。消费者可以方便地在日常饮食中摄入这些必需营养素。

市场动态

慢性病发病率的上升推动了必需脂肪酸市场的增长

随着心血管疾病、糖尿病、肥胖症和神经系统疾病等慢性疾病的发病率不断上升，人们越来越重视预防保健。根据美国疾病控制和预防中心的数据，每年有4100万人死于非传染性疾病，相当于全球每10人中就有7人死于非传染性疾病。消费者正变得更加积极主动地管理自己的健康，并寻求降低患慢性病风险的方法。因此，人们对必需脂肪酸（EFAs）的需求越来越高，将其作为支持整体健康和降低慢性疾病风险的预防措施。

EFAs因其对各种慢性疾病的潜在治疗作用而被广泛研究。例如，欧米茄3脂肪酸在治疗心血管疾病、关节炎、抑郁症和认知能力下降等疾病方面显示出良好的效果。随着人们对EFAs治疗潜力的认识不断提高，医护人员和患者正在将EFAs纳入治疗计划和饮食方案。这种日益增长的认识推动了市场对EFAs的需求。

EFA在各行各业的应用范围不断扩大，推动了必需脂肪酸市场的增长

EFAs在各行各业的应用范围不断扩大，使市场多样化并促进了市场增长。EFAs，尤其是Omega-3脂肪酸，在制药行业获得了极大的关注。这些脂肪酸对心血管疾病、炎症性疾病、精神疾病和神经退行性疾病等各种健康状况具有潜在的治疗作用。EFAs在个人护理和化妆品行业的应用日益广泛。这些脂肪酸具有促进皮肤健康、保湿和抗衰老的功效。

必需脂肪酸，尤其是Omega-3脂肪酸，在婴儿发育中起着至关重要的作用。它们对大脑发育、认知功能和视觉敏锐度至关重要。EFA对动物的健康和福利至关重要。它们被广泛用作动物饲料中的营养补充剂，以促进生长、改善免疫功能并提高家畜和水产养殖物种的整体健康水平。因此，EFA在制药、个人护理、婴幼儿营养、动物饲料、功能性食品和膳食补充剂中的应用范围不断扩大，推动了其市场的增长。

原材料供应有限制约了必需脂肪酸市场的增长

EFAs，如Omega-3脂肪酸EPA（二十碳五烯酸）和DHA（二十二碳六烯酸），主要来源于鱼类和藻类等海洋生物。由于过度捕捞、环境条件和法规限制等因素，这些来源的可获得性可能有限。对特定来源的依赖使得原料供应易受波动和供应链中断的影响。这种限制会限制EFAs的生产和供应，阻碍市场增长。

EFAs原料的可获得性会受到季节性变化和收获挑战的影响。例如，某些鱼类物种的捕捞或用于生产Omega-3脂肪酸的藻类培育可能仅限于特定季节或地区。这可能造成供应限制，影响全年EFA的稳定生产。市场参与者必须应对这些挑战，以确保原料的稳定供应。

COVID-19影响分析

COVID-19影响分析包括COVID前情景、COVID情景和COVID后情景，以及定价动态（包括大流行期间和之后的定价变化，并与COVID前情景进行比较）、供需关系（由于贸易限制、封锁和后续问题导致的供需变化）、政府倡议（政府机构为振兴市场、行业或产业而采取的倡议）和制造商战略倡议（此处将涵盖制造商为缓解COVID问题而采取的措施）。

目录

第一章 研究方法和范围

  • 研究方法
  • 研究目的和报告范围

第2章：定义和概述

第三章：执行摘要

  • 按产品类型划分
  • 按形式划分
  • 按来源划分
  • 按应用分类
  • 按地区划分

第四章 动态

  • 影响因素
    • 驱动因素
      • 人们对EFAs健康益处的认识不断提高
      • 营养缺乏日益严重
    • 限制因素
      • 生产成本高
    • 机会
      • 市场扩张和产品开发
    • 影响分析

第五章 行业分析

  • 波特五力分析法
  • 供应链分析
  • 定价分析
  • 法规分析

第六章：COVID-19分析

  • COVID-19分析
    • COVID之前的情景
    • COVID期间的情景
    • COVID之后的情景
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第七章：按产品类型

  • 欧米茄3
  • 欧米茄6
  • 欧米茄7
  • 奥米加9

第八章：按形态

  • 粉末状
  • 糖浆
  • 油类
  • 其他形态

第九章：按来源

  • 植物油
  • 肉类
  • 鱼类
  • 种子
  • 坚果
  • 其他

第10章：按应用分类

  • 营养保健品
  • 婴儿配方奶粉
  • 药品
  • 化妆品
  • 其他应用

第十一章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 日本
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第十二章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十三章 ：公司简介

    • 建明工业公司
    • 公司概况
    • 产品组合和描述
    • 财务概况
    • 主要发展
  • 建明制药集团
  • 上海医药集团
  • 阿克尔生物海洋公司
  • 帝斯曼集团
  • 克罗达国际有限公司
  • 陶氏化学公司
  • Arbee Agencies
  • Arjuna Natural LLC
  • Arctic Nutrition

第十四章：附录

简介目录
Product Code: FB6505

Market Overview

The Global Essential Fatty Acids Market reached US$ 4.6 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 8.5 billion by 2030. The market is growing at a CAGR of 8.1% during the forecast period 2023-2030.

The global focus on health and wellness is growing, which has led to increased consumer awareness about the significance of nutrition in overall well-being. Consumers are actively searching for dietary interventions and supplements that provide health benefits including essential fatty acids (EFAs) which drive the market growth.

This increasing trend is driving the global demand for EFA products. Additionally, EFAs are being utilized in applications beyond dietary supplements, particularly in the functional foods and beverages sector. Manufacturers are incorporating EFAs into various products such as fortified beverages, energy bars, cereals, and bakery items. By integrating EFAs into functional foods. Consumers can conveniently include these essential nutrients in their regular diets

Market Dynamics

Increasing Prevalence of Chronic Diseases Fuels the growth of the Essential Fatty Acids Market

With the increasing burden of chronic diseases, such as cardiovascular diseases, diabetes, obesity, and neurological disorders, there is a growing emphasis on preventive healthcare. According to the Centers for Disease Control and Prevention, each year, NCDs kill 41 million people, which is equivalent to more than 7 out of 10 people worldwide. Consumers are becoming more proactive in managing their health and seeking ways to reduce the risk of developing chronic conditions. As a result, there is a higher demand for essential fatty acids (EFAs) as a preventive measure to support overall well-being and reduce the risk of chronic diseases.

EFAs have been extensively studied for their potential therapeutic effects on various chronic diseases. For example, Omega 3 fatty acids have shown promising results in managing conditions such as cardiovascular diseases, arthritis, depression, and cognitive decline. As awareness regarding the therapeutic potential of EFAs grows healthcare professionals and patients are incorporating EFAs into treatment plans and dietary regimens. This growing recognition drives the demand for EFAs in the market.

Expanding Application Scope of EFAs Across Various Industries Fuels the Market Growth Of Essential Fatty Acids

The expanding application scope of EFAs across various industries diversifies the market and fuels the market growth. EFAs, particularly Omega-3 fatty acids, have gained significant attention in the pharmaceutical industry. These fatty acids have shown potential therapeutic benefits in various health conditions such as cardiovascular diseases, inflammatory disorders, psychiatric disorders, and neurodegenerative diseases. EFAs are increasingly being utilized in the personal care and cosmetics industry. These fatty acids offer benefits for skin health, hydration, and anti-aging properties.

Essential fatty acids, especially Omega-3 fatty acids, play a crucial role in infant development. They are vital for brain development, cognitive function, and visual acuity. EFAs are essential for animal health and well-being. They are widely used as nutritional supplements in animal feed to promote growth, improve immune function, and enhance overall health in livestock and aquaculture species. Hence, EFA's expanding range of applications in pharmaceuticals, personal care, infant nutrition, animal feed, functional foods, and dietary supplements is driving its market growth.

Limited Availability of Raw Materials is Restraining the Market Growth Of Essential Fatty Acids Market

EFAs, such as Omega-3 fatty acids EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid), are predominantly sourced from marine organisms like fish and algae. These sources may have limited availability due to factors such as overfishing, environmental conditions, and regulatory restrictions. The reliance on specific sources makes the availability of raw materials vulnerable to fluctuations and supply chain disruptions. This constraint can limit the production and availability of EFAs, hindering market growth.

The availability of raw materials for EFAs can be affected by seasonal variations and challenges in harvesting. For example, the harvesting of certain fish species or the cultivation of algae for Omega-3 fatty acids may be limited to specific seasons or regions. This can create supply constraints and impact the consistent production of EFAs throughout the year. Market players must navigate these challenges to ensure a stable supply of raw materials.

COVID-19 Impact Analysis

The COVID-19 Analysis includes Pre-COVID Scenario, COVID Scenario, and Post-COVID Scenario along with Pricing Dynamics (Including pricing change during and post-pandemic comparing it to pre-COVID scenarios), Demand-Supply Spectrum (Shift in demand and supply owing to trading restrictions, lockdown, and subsequent issues), Government Initiatives (Initiatives to revive market, sector or Industry by Government Bodies) and Manufacturers Strategic Initiatives (What manufacturers did to mitigate the COVID issues will be covered here).

Segment Analysis

The global essential fatty acids market is segmented based on product type, form, application, distribution channel, and region.

The Abundance of Omega-3 Fatty Acids in Fish

Based on source, essential fatty acids are classified into vegetable oils, meat, fish, seeds, nuts, and others.

In 2022, fish had the highest share in the essential fatty acids market. The fish segment is commonly recognized as one of the significant sources of Essential Fatty Acids (EFAs), particularly Omega-3 fatty acids. Fish, especially fatty fish like salmon, mackerel, and sardines, are known for their high Omega-3 content, specifically EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid). As a result, the fish segment often holds a prominent share in the EFAs market.

Fatty fish species are known to naturally accumulate Omega-3 fatty acids in their tissues. This natural abundance makes fish a valuable source for extracting EFAs, particularly EPA and DHA. The high Omega-3 content in fish contributes to the segment's significant market share.

Geographical Analysis

Growing Awareness of the Role of EFAs in the Asia-Pacific Region

In 2022, Asia Pacific has a significant share of the EFAs market. According to the Department of Biotechnology, India, India has the highest number of people with Diabetes in the world with around 77 million living with diabetes and a projection of 134 million by 2045 (International Diabetes Federation). India suffers loss of life at an early age due to cardiovascular disease which accounts for one-fourth of all deaths. EFAs, particularly Omega-3 fatty acids, have been extensively studied for their potential cardiovascular benefits, including reducing triglyceride levels, improving heart health, and managing blood pressure. The growing awareness of the role of EFAs drives the demand for EFAs products in the region.

Many countries in the Asia Pacific region have a long history of consuming Omega-3-rich foods, such as fish and seafood. Traditional diets in countries like Japan and South Korea include a significant amount of fish, which naturally provides Omega-3 fatty acids. This cultural preference and familiarity with Omega-3-rich foods contribute to the demand for EFAs in the region.

Competitive Landscape

The major global players include: Kemin Industries, Inc, KD Pharma Group, SEPPIC, Aker BioMarine AS, Koninklijke DSM NV, Croda International Plc, The Dow Chemical Company, Arbee Agencies, Arjuna Natural LLC, Arctic Nutrition.

Why Purchase the Report?

  • To visualize the global Essential Fatty Acids extract market segmentation based on product type, form, source, application, and region understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous Essential Fatty Acids extract market-level data points all for segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as excel consisting of key products of all the major players.

The Global Essential Fatty Acids Extract Market Report Would Provide Approximately 69 Tables, 74 Figures And 102 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Form
  • 3.3. Snippet by Source
  • 3.4. Snippet by Application
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Awareness of the Health Benefits of EFAs
      • 4.1.1.2. Increasing Nutritional Deficiencies
    • 4.1.2. Restraints
      • 4.1.2.1. The High Cost of Production
    • 4.1.3. Opportunity
      • 4.1.3.1. Market Expansion and Product Development
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID
    • 6.1.2. Scenario During COVID
    • 6.1.3. Scenario Post COVID
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Omega 3*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Omega 6
  • 7.4. Omega 7
  • 7.5. Omega 9

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Powder*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Syrup
  • 8.4. Oil
  • 8.5. Others

9. By Source

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 9.1.2. Market Attractiveness Index, By Source
  • 9.2. Vegetable Oils*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Meat
  • 9.4. Fish
  • 9.5. Seeds
  • 9.6. Nuts
  • 9.7. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Nutraceuticals*
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Infant Formula
  • 10.4. Pharmaceuticals
  • 10.5. Cosmetics
  • 10.6. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

    • 13.1.1. Kemin Industries Inc,*
    • 13.1.2. Company Overview
    • 13.1.3. Product Portfolio and Description
    • 13.1.4. Financial Overview
    • 13.1.5. Key Developments
  • 13.2. KD Pharma Group
  • 13.3. SEPPIC
  • 13.4. Aker BioMarine AS
  • 13.5. Koninklijke DSM NV
  • 13.6. Croda International Plc
  • 13.7. The Dow Chemical Company
  • 13.8. Arbee Agencies
  • 13.9. Arjuna Natural LLC
  • 13.10. Arctic Nutrition

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us